EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Melanoma update: is a cure now in sight?

Samrin Liaqat iD, Muhammad Adnan Khattak

Internal Medicine Journal · 2025

DOI: 10.1111/imj.70085 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Samrin Liaqat und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Fiona Stanley Hospital, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Immunotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma, one of the most aggressive skin cancers, poses a significant global health concern due to its high metastatic potential and resistance to conventional treatments. This review explores recent advancements in melanoma treatment, particularly the impact of targeted therapies and immunotherapies which have significantly extended survival and improved the quality of life for advanced melanoma patients. Additionally, the innovative combination and sequential strategies, with immune checkpoint inhibitors and cancer vaccines or targeted therapies against BRAF mutations, mark a promising direction. Recent advances in tumour infiltrating lymphocytes and oncolytic virus therapy and personalised cancer vaccine development are also covered, highlighting the role of precision medicine in achieving tailored, effective treatments. Despite these advancements, challenges persist, including drug resistance and the need for reliable biomarkers to predict treatment response and select patients. This review underscores the ongoing efforts in research and clinical trials to refine therapeutic strategies, improve treatment outcomes for a larger population detection and, ultimately, advance towards a cure for melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsImmunotherapyHumansImmune Checkpoint InhibitorsCancer VaccinesMolecular Targeted TherapyPrecision Medicine

Stichwörter der Autor:innen

cancer vaccineimmunotherapymelanomatargeted therapytumour‐infiltrating lymphocyte

Substanzen

Immune Checkpoint InhibitorsCancer Vaccines

Autor:innen und Institutionen

  • Department of Medical Oncology, Fiona Stanley Hospital, Perth, Western Australia, Australia.

ORCID-Profile: Samrin Liaqat

Zitieren

APA

Liaqat, S., & Khattak, M. A. (2025). Melanoma update: is a cure now in sight?. Internal Medicine Journal. https://doi.org/10.1111/imj.70085

Vancouver

Liaqat S, Khattak MA. Melanoma update: is a cure now in sight?. Internal Medicine Journal. 2025. doi:10.1111/imj.70085

BibTeX
@article{Liaqat2025,
  author = {Liaqat, Samrin and Khattak, Muhammad Adnan},
  title = {Melanoma update: is a cure now in sight?},
  journal = {Internal Medicine Journal},
  year = {2025},
  doi = {10.1111/imj.70085}
}
Kostenlos starten →